ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Walgreens Announces Over-the-Counter (OTC) NARCAN® Nasal Spray Will Become Available This September

In support of the launch, the healthcare company, in partnership with non-profit End Overdose, is educating Americans on how to administer this lifesaving medication that can reverse the effects of an opioid overdose if used in time.

Walgreens is taking an important step to increase access to and education around naloxone by announcing that over-the-counter (OTC) NARCAN® Nasal Spray will be available at Walgreens stores and online as soon as Sept. 5, with nationwide availability on Sept. 7. This announcement follows the U.S. Food and Drug Administration’s (FDA) approval earlier this year.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230830719236/en/

This lifesaving medication can be used in the event of an opioid overdose to temporarily reverse the effects of opioids. Naloxone counteracts life-threatening depression of the central nervous and respiratory systems, allowing overdose victims to breathe normally again.

“We are committed to educating and making it easier for all Americans to have this life-saving medicine available in their first aid kits in case of an emergency,” said Kevin Ban, M.D. executive vice president and Walgreens chief medical officer. “We all must recognize that overdoses can happen to anyone, regardless of age, background or other factors. As a leading healthcare company, providing access to OTC naloxone creates an opportunity for bystanders, friends and family members to potentially save a life. In the event of an overdose, every second matters.”

Naloxone should be administered as soon as someone shows signs of an opioid overdose and does not take the place of emergency medical care. It’s important to call 911 immediately.

OTC NARCAN® Nasal Spray will retail at Walgreens stores for $44.99.

To educate the public on how to use this lifesaving nasal spray, Walgreens is working with End Overdose, a non-profit organization dedicated to ending drug-related overdose deaths through education, medical intervention and public awareness.

Together, Walgreens and End Overdose have created an educational preparedness video that explains how an overdose can happen anywhere and affect anyone, how to recognize an overdose and how to respond with naloxone nasal spray. This video is available on Walgreens YouTube channel and walgreens.com/topic/pharmacy/naloxone.jsp.

“This community-first effort with Walgreens will hopefully empower everyone to feel comfortable carrying and administering naloxone nasal spray,” said Theo Krzywicki, CEO and founder of End Overdose. “Just as you might carry other first aid items, this can and should be something that is accessible to all.”

In addition to the awareness video, Walgreens is making a $100,000 donation to End Overdose to support its continuing efforts in educating the public on how to use this life-saving nasal spray and de-stigmatizing the conversation around overdose and substance use disorder.

As part of the company’s other ongoing efforts to address unsafe drug use, Walgreens offers a National Prescription Drug Take Back program. The program encourages the public to collect unwanted, unused or expired medications for safe disposal at no cost, year-round by visiting a Walgreens safe medication disposal kiosk during regular pharmacy hours. Kiosk locations can be found on walgreens.com via the store locator.

To learn more about Walgreens efforts and to watch the educational preparedness video, visit walgreens.com/topic/pharmacy/naloxone.jsp.

About Walgreens

Walgreens (www.walgreens.com) is included in the U.S. Retail Pharmacy and U.S. Healthcare segments of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), an integrated healthcare, pharmacy and retail leader with a 170-year heritage of caring for communities. WBA’s purpose is to create more joyful lives through better health. Operating nearly 9,000 retail locations across America, Puerto Rico and the U.S. Virgin Islands, Walgreens is proud to be a neighborhood health destination serving nearly 10 million customers each day. Walgreens pharmacists play a critical role in the U.S. healthcare system by providing a wide range of pharmacy and healthcare services, including those that drive equitable access to care for the nation’s medically underserved populations. To best meet the needs of customers and patients, Walgreens offers a true omnichannel experience, with fully integrated physical and digital platforms supported by the latest technology to deliver high-quality products and services in communities nationwide.

About End Overdose

End Overdose is a 501(c)3 non-profit organization working to end drug-related overdose deaths through education, medical intervention, and public awareness. We seek to increase accessibility and visibility of life saving treatments and medication nationwide.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.22
+21.36 (9.58%)
AAPL  270.37
-1.03 (-0.38%)
AMD  256.12
+1.28 (0.50%)
BAC  53.45
+0.42 (0.79%)
GOOG  281.82
-0.08 (-0.03%)
META  648.35
-18.12 (-2.72%)
MSFT  517.81
-7.95 (-1.51%)
NVDA  202.49
-0.40 (-0.20%)
ORCL  262.61
+5.72 (2.23%)
TSLA  456.56
+16.46 (3.74%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.